Agios Pharmaceuticals Inc... (AGIO)
NASDAQ: AGIO
· Real-Time Price · USD
37.00
0.32 (0.87%)
At close: Aug 15, 2025, 3:59 PM
37.14
0.38%
After-hours: Aug 15, 2025, 07:37 PM EDT
Agios Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 12.46M | 8.73M | 10.73M | 8.96M | 8.62M | 8.19M | 7.1M | 7.4M | 6.71M | 5.61M | 4.31M | 3.52M | 5.58M | 832K | n/a | n/a | 37.35M | 41.41M |
Cost of Revenue | 2.96M | 1.08M | 1.26M | 783K | 3.09M | 1.98M | 1.99M | 633K | 1.11M | 554K | 413K | 517K | 435K | 339K | 4.61M | 4.58M | 675K | 706K |
Gross Profit | 9.49M | 7.64M | 9.47M | 8.18M | 5.53M | 6.21M | 5.11M | 6.77M | 5.6M | 5.05M | 3.9M | 3M | 5.15M | 493K | -4.61M | -4.58M | 36.67M | 40.7M |
Operating Income | -127.06M | -106.63M | -125.04M | -102.81M | -105.82M | -92.07M | -106.28M | -100.9M | -93.7M | -90.61M | -99.17M | -91.09M | -97.64M | -101.14M | -104.83M | -91.15M | -91.22M | -91.22M |
Interest Income | 14.51M | n/a | 18.02M | 13.06M | 8.12M | 8.89M | 8.62M | 8.38M | 8.25M | 8.09M | 6.49M | 3.82M | 1.79M | 694K | 332K | 256K | n/a | 340K |
Pretax Income | -112.02M | -89.29M | -105.4M | 1B | -96.12M | -81.55M | -95.94M | -91.32M | -83.81M | -81.02M | 36.53M | -81.75M | -91.81M | -94.77M | -98.58M | -84.26M | -82.79M | -90.88M |
Net Income | -112.02M | -89.29M | -96.52M | 947.91M | -96.12M | -81.55M | -95.94M | -91.32M | -83.81M | -71.42M | 172.22M | -72.4M | -91.81M | -88.4M | -94.63M | -88.77M | -86.22M | 1.87B |
Selling & General & Admin | 45.87M | 41.53M | 51.7M | 38.54M | 35.54M | 31.01M | 35.3M | 25.82M | 30.41M | 28.37M | 32.77M | 29.12M | 28.26M | 31.52M | 31.53M | 27.15M | 29.21M | 33.55M |
Research & Development | 90.68M | 72.74M | 82.81M | 72.45M | 75.81M | 67.27M | 76.09M | 81.84M | 68.89M | 67.3M | 70.3M | 64.97M | 74.52M | 70.12M | 73.3M | 64M | 62.01M | 57.67M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3.27M | 4.64M | n/a | n/a |
Operating Expenses | 136.55M | 114.27M | 134.51M | 110.99M | 111.34M | 98.29M | 111.39M | 107.66M | 99.3M | 95.67M | 103.07M | 94.09M | 102.79M | 101.64M | 104.83M | 91.15M | 91.22M | 91.22M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 139.51M | 115.36M | 135.77M | 111.78M | 114.43M | 100.26M | 113.38M | 108.3M | 100.41M | 96.22M | 103.48M | 94.61M | 103.22M | 101.98M | 104.83M | 91.15M | 91.22M | 91.22M |
Income Tax Expense | n/a | n/a | -8.88M | 53.12M | n/a | n/a | n/a | n/a | n/a | -9.6M | -135.7M | -9.34M | n/a | -6.37M | 332K | n/a | 1.52M | n/a |
Shares Outstanding (Basic) | 57.93M | 57.46M | 57.16M | 56.94M | 56.8M | 56.38M | 55.9M | 55.8M | 55.5M | 55.11M | 54.79M | 54.84M | 54.8M | 54.47M | 54.34M | 57.05M | 61.07M | 69.54M |
Shares Outstanding (Diluted) | 57.93M | 57.46M | 57.16M | 58.43M | 56.8M | 56.38M | 55.9M | 55.8M | 55.6M | 55.27M | 54.79M | 54.84M | 54.8M | 54.56M | 54.34M | 57.05M | 61.07M | 69.54M |
EPS (Basic) | -1.93 | -1.55 | -1.7 | 16.65 | -1.69 | -1.45 | -1.72 | -1.64 | -1.51 | -1.3 | 3.14 | -1.32 | -1.68 | -1.62 | -1.74 | -1.56 | -1.41 | 26.95 |
EPS (Diluted) | -1.93 | -1.55 | -1.67 | 16.22 | -1.69 | -1.45 | -1.72 | -1.64 | -1.51 | -1.29 | 3.14 | -1.32 | -1.68 | -1.62 | -1.74 | -1.56 | -1.41 | 26.95 |
EBITDA | -110.76M | -105.35M | -123.67M | -102.81M | -104.22M | -90.72M | -104.87M | -99.27M | -91.89M | -88.82M | -97.36M | -89.11M | -95.35M | -98.67M | -102.63M | -88.94M | -88.87M | -88.74M |
EBIT | -112.02M | -106.63M | -125.04M | -102.81M | -105.82M | -92.07M | -106.28M | -100.9M | -93.7M | -90.61M | -99.17M | -91.09M | -97.64M | -101.14M | -104.83M | -91.15M | -91.22M | -91.22M |
Depreciation & Amortization | 1.26M | 1.28M | 1.37M | 1.34M | 1.59M | 1.35M | 1.4M | 1.62M | 4.46M | 4.4M | 4.38M | 4.49M | 4.77M | 4.91M | 4.61M | 4.58M | 4.69M | 4.9M |